Immunotherapy comes of age: Immune aging & checkpoint inhibitors
Author:
Publisher
Elsevier BV
Subject
Geriatrics and Gerontology,Oncology
Reference124 articles.
1. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy;Peggs;Immunol Rev,2008
2. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion;Kavanagh;Blood,2008
3. Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells;Doyle;J Exp Med,2001
4. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses;Walker;Nat Rev Immunol,2011
5. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma;Simpson;J Exp Med,2013
Cited by 108 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Entering the TiME machine: How age-related changes in the tumor immune microenvironment impact melanoma progression and therapy response;Pharmacology & Therapeutics;2024-10
2. Age-related efficacy of immunotherapies in advanced non-small cell lung cancer: a comprehensive meta-analysis;Lung Cancer;2024-09
3. Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study;Drugs & Aging;2024-05
4. Regorafenib combined with a PD-1 inhibitor in the second-line setting for unresectable hepatocellular carcinoma in real-world practice;Journal of Gastrointestinal Oncology;2024-02
5. Immunosenescence and immunotherapy in older NSCLC patients;Journal of Cancer Research and Therapeutics;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3